Vaccine adverse reaction papers

A partial list of papers in the peer-reviewed literature documenting adverse reactions after the vaccine. There are over 3,400 papers now.

May 27, 2022

Finding and Learning about Side Effects (adverse reactions) | FDA

Update

Here’s an even larger list of articles published in peer-reviewed journals: 3,400 articles.

My list of nearly 500 articles

I didn’t compile the list below. Someone else did, but I don’t know who did because they didn’t put their name on the Word file presumably because they wanted to remain anonymous.

Neuro:

General Neuro side effects: https://onlinelibrary.wiley.com/doi/full/10.1111/ane.13451?fbclid=IwAR1CemFwLUpsMK19GMZa_xPF775Q4B0IiksbrziKUpIrRXhYR5cDQFFfVAQ

Small fiber neuropathy: https://onlinelibrary.wiley.com/doi/10.1002/mus.27251...

2 cases of Parsonage Turner Syndrome following Moderna and Pfizer: https://pubmed.ncbi.nlm.nih.gov/34402669/

Trigeminal Neuralgia and cervical radiculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34155020/

Neuralgic amyotrophy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34347105/

Amyotrophic neuralgia secondary to AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34330677/

36yoM with transverse myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/33787891/

Acute Myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34392078/

67yoF with transverse myelitis following Moderna 1st dose: https://pubmed.ncbi.nlm.nih.gov/34482455/

Longitudinal extensive transverse myelitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34507942/

Transverse Myelitis and Bells Palsy after J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34458035/

Recurrent GBS following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34468703/

GBS following Johnson and Johnson: https://www.onlinescientificresearch.com/articles/the-development-of-guillain-barre-syndrome-subsequent-to-administration-of-ad26cov2s-vaccine.pdf

4 cases of GBS following Astra Zeneca:

https://pubmed.ncbi.nlm.nih.gov/34114269/

GBS following 2nd dose of Pfizer:: https://pubmed.ncbi.nlm.nih.gov/34347563/

GBS after the first dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/33758714/

GBS in a 25yoF following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34346014/

GBS in a 61yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34484780/

GBS in a 65yoM liver transplant patient following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34431208/

GBS in a 73yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34477091/

GBS in 73yoM following 2nd dose of Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253659/

GBS in 82yoF following 1st dose Pfizer: https://pubmed.ncbi.nlm.nih.gov/33758714/

GBS 10 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34272622/

GBS 11 days after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34187803/

GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34330729/

7 cases of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34114256/

GBS following AstraZeneca with papilledema as atypical onset: https://pubmed.ncbi.nlm.nih.gov/34418708/

2 cases of Sensory GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416410/

Bilateral facial weakness with paresthesia variant of GBS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34261746/

Bifacial diplegia variant of GBS following J&J vaccination: https://pubmed.ncbi.nlm.nih.gov/34449715/

Facial Weakness, extremity weakness, encephalopathy, and severe refractory ITP following Moderna: https://pubmed.ncbi.nlm.nih.gov/33854395/

Transient akathisia after Pfizer:

https://pubmed.ncbi.nlm.nih.gov/34113842/

Phantosmia: https://pubmed.ncbi.nlm.nih.gov/34096896/

21yoF nurse with Bells Palsy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34322761/

34yoF with Bells Palsy 2 days after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143982/

36yo with Bells Palsy, left arm tingling/numbness/weakness following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34336436/

37yoM with Bells Palsy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/33611630/

50yoM with Bells Palsy after Pfizer, ongoing symptoms after 21 days: https://pubmed.ncbi.nlm.nih.gov/34330676/

57yoF with Bells Palsy <36 hours after 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/33594349/

61yoM with Bells Palsy after each dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34281950/

Bells Palsy following mRNA and inactivated (CoronaVac) vaccines: a case series and nested case-control study: https://pubmed.ncbi.nlm.nih.gov/34411532/

Rate of Bells Palsy following mRNA vaccination is 2-3x higher then expected: https://pubmed.ncbi.nlm.nih.gov/34111409/

Neuromyelitis optica spectrum disorder (NMOSD): https://link.springer.com/article/10.1007/s10072-021-05427-4?fbclid=IwAR2DGcW8Y5UxvdzcOQaBUPn6_RTZGQRSsNo6bzanyAm9yN6387E3Z6WrKlI

Patient’s first MS Flare following Pfizer:

https://link.springer.com/article/10.1007/s00415-021-10648-w

4 cases of activation of stable MS, 2 cases of new MS, 1 case of new onset neuromyelitis optica after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34480607/

Severe Multiple Sclerosis relapse after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34447349/

Optic neuritis and transverse myelitis in MS patient after Astrazeneca vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205198/

Myasthenia Gravis Flare Following Moderna: https://www.cureus.com/articles/60348-a-case-of-covid-19-vaccine-causing-a-myasthenia-gravis-crisis

CVA and Thrombocytopenia following Astrazeneca: https://pubmed.ncbi.nlm.nih.gov/34175640/

Central venous sinus thrombosis with subarachnoid hemorrhage in a 45yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34478433/

Cerebral venous thrombosis and pulmonary embolus following AstraZeneca: https://www.sciencedirect.com/.../pii/S0196064421003425

Cerebral venous sinus thrombosis after AstraZeneca, neurologic and radiological management: https://pubmed.ncbi.nlm.nih.gov/34327553/

Cerebral venous sinus thrombosis, subarachnoid hemorrhage, and thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34485807/

Cerebral Venous sinus thrombosis, review of European cases: https://pubmed.ncbi.nlm.nih.gov/34293217/

Review of European data of Cerebral venous thrombosis with cytopenia, observed in Pfizer, Moderna, and AstraZeneca https://pubmed.ncbi.nlm.nih.gov/34375510/

A multicenter cohort study of cerebral venous thrombosis after AstraZeneca Vaccination: https://pubmed.ncbi.nlm.nih.gov/34370972/

45 cases of Cerebral Venous thrombosis: https://pubmed.ncbi.nlm.nih.gov/34288044/

International Cerebral Venous Thrombosis consortium report on cerebral venous thrombosis following vaccination against SARS-COV-2: https://pubmed.ncbi.nlm.nih.gov/34462996/

Fatal ICH following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34477089/

Treatment of AstraZeneca induced immume thrombotic thrombocytopenia related acute ischemic stroke: https://pubmed.ncbi.nlm.nih.gov/34461442/

Worsening Neuro-Oncologic Disease Symptoms following mRNA vaccination: https://www.cureus.com/articles/61880-new-onset-neurologic-symptoms-and-related-neuro-oncologic-lesions-discovered-after-covid-19-vaccination-two-neurosurgical-cases-and-review-of-post-vaccine-inflammatory-responses

Clinical characteristics of Headache following Pfizer, a multicenter observational cohort study: https://pubmed.ncbi.nlm.nih.gov/34405142/

Aseptic Meningitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34378098/

Delirium in an elderly patient following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/ggi.14163

Delirium in an elderly patient following vaccination: https://pubmed.ncbi.nlm.nih.gov/33829614/

Two cases of encephalopathy and seizures following Moderna: https://pubmed.ncbi.nlm.nih.gov/34367780/

Acute disseminated encephalitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294707/

Acute Disseminated Encephalitis in a young female following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34480527/

Postvaccinal encephalitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34324214/

Acute encephalitis, myoclonus, and sweet syndrome after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34312136/

New onset psychosis in 31yoM after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34388513/

Severe dyskinesia in Parkinson Patient following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34368991/

Cytotoxic lesion of the Corpus Callousum following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34402238/

Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34432055/

Three cases: CVA, left facial nerve palsy, and myelitis all following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34507266/

Headache after AstraZeneca: a MultiCenter observational cohort center: https://pubmed.ncbi.nlm.nih.gov/34313952/

Characteristics of COVID vaccine induced Headache: https://pubmed.ncbi.nlm.nih.gov/34510919/

Covid Vaccines are not free of Neurologic side effects: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206845/

Rebuttal about Functional Neurologic Disorders and Vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/ana.26160?fbclid=IwAR3C-QQc-ZDEDoCu0fWNQuVYzvbC3qYHGekCaicU5-l_bOUz4N52jl1wjJ0

Neurologic safety monitoring of COVID-19 vaccines, lessons learned from the past to inform the present: https://pubmed.ncbi.nlm.nih.gov/34475124/

Cardiac:

Myocarditis in 23 military members: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601

Perimyocarditis in teens: https://pubmed.ncbi.nlm.nih.gov/34077949/

Vaccination associated myocarditis in Adolescents: https://pubmed.ncbi.nlm.nih.gov/34389692/

mRNA vaccination and myocarditis in adolescents: https://pubmed.ncbi.nlm.nih.gov/34393110/

Association of myocarditis with mRNA vaccination, a case review in children: https://pubmed.ncbi.nlm.nih.gov/34374740/

Recurrence of myocarditis after vaccination: https://pubmed.ncbi.nlm.nih.gov/34166671/

Myopericarditis in young adults presenting to the ED: https://pubmed.ncbi.nlm.nih.gov/34310793/

Pericarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34364831/

Myocarditis following J&J in a healthy, young male: https://pubmed.ncbi.nlm.nih.gov/34420869/

Acute myocarditis after Moderna in young male: https://pubmed.ncbi.nlm.nih.gov/34308326/

Myocarditis in a healthy male: https://pubmed.ncbi.nlm.nih.gov/34229940/

Acute myocarditis following vaccination: https://pubmed.ncbi.nlm.nih.gov/34331307/

Acute myocarditis following Pfizer in a healthy man with previous COVID infection: https://pubmed.ncbi.nlm.nih.gov/34367386/

Myocarditis case report: https://pubmed.ncbi.nlm.nih.gov/34118375/

Myocarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34393273/

Myocarditis in 24yoM: https://pubmed.ncbi.nlm.nih.gov/34268277/

Myocarditis in a 24yoM nurse after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34400043/

Myocarditis in a 15yo following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369878/

Myopericarditis in a 16yo following vaccination:

https://pubmed.ncbi.nlm.nih.gov/34133825/

Myocarditis in a 22yoM following Moderna: https://pubmed.ncbi.nlm.nih.gov/34348657/

70yoF with myocarditis following J&J Vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270733/

Biopsy proven lymphocytic myocarditis following 1st mRNA vaccination in a 40yo: https://pubmed.ncbi.nlm.nih.gov/34487236/

Cardiac imaging of acute myocarditis following mRNA in a 24yoM: https://pubmed.ncbi.nlm.nih.gov/34402228/

Cardiac MRI findings in young adults following mRNA vaccination: a case series: https://pubmed.ncbi.nlm.nih.gov/34496880/

Myopericarditis following mRNA vaccination: the role of cardiac biomarkers and multimodality imaging: https://pubmed.ncbi.nlm.nih.gov/34487161/

Myocarditis should be consider in those with a troponin rise and unobstructed arteries following Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34463755/

Myocarditis Associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings: https://pubmed.ncbi.nlm.nih.gov/34428917/

Fulminant myocarditis and systemic hyperinflammation in 2 patients following mRNA: https://pubmed.ncbi.nlm.nih.gov/34416319/

2 cases of histological confirmed myocarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34407340/

Myocarditis and Pericarditis: 2 case reports: https://pubmed.ncbi.nlm.nih.gov/34277198/

Two cases of myocarditis:

https://pubmed.ncbi.nlm.nih.gov/34166884/

Two cases of myocarditis:

https://pubmed.ncbi.nlm.nih.gov/34166884/

3 cases of cardiac manifestation following Pfizer: https://academic.oup.com/qjmed/advance-article/doi/10.1093/qjmed/hcab177/6311674

4 cases of Myocarditis and their Cardiac MRI findings: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245050/

4 cases of myocarditis: https://pubmed.ncbi.nlm.nih.gov/34396358/

6 cases of men age 17-37 with myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219373/

8 cases of myocarditis in adolescents following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34319393/

13 cases of Myocarditis in adolescents following Pfizer: https://www.jpeds.com/article/S0022-3476(21)00665-X/fulltext

Review of 15 published cases of myocarditis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272967/

Review of 29 published cases of acute myopericarditis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34356586/

Review of 214 myocarditis cases:: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233865/

JAMA article, concerns for perimyocarditis underreporting, review of 40 hospitals: https://jamanetwork.com/journals/jama/fullarticle/2782900

Intravenous injection of mRNA vaccine can induce acute myopericarditis in mouse model: https://pubmed.ncbi.nlm.nih.gov/34406358/

The Novel platform of mRNA vaccines and myocarditis: clues into the potential underlying mechanism: https://pubmed.ncbi.nlm.nih.gov/34312010/

3 cases of acute infarct-like myocarditis (2 Pfizer, 1 AstraZeneca): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325525/

2 cases of acute MI <24 hours after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34364657/

Acute STEMI MI following AstraZeneca vaccination,?Kounis syndrome?: https://pubmed.ncbi.nlm.nih.gov/34394944/

Vaccine induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34486030/

Frequent PVS and NSVT following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34275963/

Isolated tachycardia in a 29yoF following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34466331/

Covid-19 vaccine associated Takotsubo cardiomyopathy: https://pubmed.ncbi.nlm.nih.gov/34375049/

63yoF with Takotsubo cardiomyopathy following Moderna: https://pubmed.ncbi.nlm.nih.gov/34330629/

Tachycardia following Pfizer: 3 cases in those previously infected with COVID-19: https://pubmed.ncbi.nlm.nih.gov/33858709/

Dizziness, HTN and new LBBB following AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34508485/

GI:

Gastroparesis following Pfizer: https://journals.lww.com/ajg/Citation/9900/Gastroparesis_After_Pfizer_BioNTech_COVID_19.28.aspx

Acute Necrotizing Pancreatitis following 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423463/

Acute Pancreatitis in a 96yoF following 1st dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34084669/

Cutaneous hypersensitivity reaction with acute hepatitis following Pfizer 2nd dose: https://pubmed.ncbi.nlm.nih.gov/34485657/

41yo F with Autoimmune hepatitis following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197609/

76yoF with autoimmune hepatitis following Moderna Vaccination: https://pubmed.ncbi.nlm.nih.gov/34332438/

71yoF with Autoimmune hepatitis after mRNA vaccine (Moderna): https://www.sciencedirect.com/science/article/pii/S0168827821018961?via%3Dihub

80yoF with autoimmune hepatitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186938/

63yoM with autoimmune hepatitis following Moderna: https://pubmed.ncbi.nlm.nih.gov/34293683/

61yoF with liver injury following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34430106/

35yoF with autoimmune hepatitis following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056822/

New Onset autoimmune hepatitis following mRNA vaccination in a 36yoF with Primary Sclerosing Cholangitis: https://pubmed.ncbi.nlm.nih.gov/34450237/

56yoF with autoimmune hepatitis following Moderna: https://www.journal-of-hepatology.eu/article/S0168-8278(21)00424-4/fulltext

Two cases of autoimmune hepatitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34225251/

Liver injury in a liver transplant patient following mRNA vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214934/

16 cases of liver injury following Pfizer and Moderna: a multicenter case series: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324396/

Reactivation of Hepatitis C infection following Pfizer in a 82yoF: https://www.dovepress.com/hepatitis-c-virus-reactivation-following-covid-19-vaccination--a-case--peer-reviewed-fulltext-article-IMCRJ?fbclid=IwAR3u0x1baFcAZz1eOrNsXsgmrlUYt0EJV2SmoXA75RiplFQbPrtSAIo2GAs

Unusual fever, HA, and abdominal pain in a healthy woman following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34339677/

Hepatic vein thrombosis due to TTS following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34432063/

Renal:

ANCA glomerulonephritis after Moderna: https://www.kidney-international.org/article/S0085-2538(21)00555-X/fulltext

New onset ANCA vasculitis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34280507/

ANCA associated Glomerulonephritis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34423176/

Nephrotic Syndrome following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257404/

New onset Nephrotic syndrome following J&J: https://pubmed.ncbi.nlm.nih.gov/34342187/

Nephrotic syndrome and vasculitis following Pfizer, Moderna, and AstraZeneca: https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfab215/6318785

De novo vasculitis after Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166777/

ANCA associated vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416184/

IgA and crescentic glomerulonephritis following Pfizer:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141343/

Minimal Change Disease Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33839200/

Minimal Change Disease relapse following Pfizer: https://www.ajkd.org/article/S0272-6386(21)00627-2/fulltext

MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137360/

MCD relapse following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/

Severe MCD relapse 3 days following Pfizer: https://europepmc.org/article/pmc/pmc8156905

Minimal change disease and AKI following Pfizer: https://www.kidney-international.org/article/S0085-2538(21)00493-2/pdf

Minimal Change disease following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/

Minimal Change disease and Severe AKI following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34242687/

3 cases of minimal change disease following 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34337193/

IgA nephropathy in 2 pediatric patients after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256683/

3 cases of IgA nephropathy patients developing exacerbations following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166778/

2 cases of IgA nephropathy patients developing exacerbations following moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987498/

IgA nephropathy flare up following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079938/

IgA Nephropathy after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34278290/

2 cases of IgA Nephropathy patients developing hematuria after Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329426/

Reactivation of IgA vasculitis following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260100/

IgA vasculitis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34509658/

IgA nephropathy flare-up following vaccination: https://pubmed.ncbi.nlm.nih.gov/34415336/

Membranous nephropathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34419553/

Membranous nephropathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34332960/

Renal Thrombotic Microangiopathy following Pfizer in a 35yoM: https://pubmed.ncbi.nlm.nih.gov/34451509/

Rheumatology/Endocrinology/Orthopedics:

Lupus exacerbation: https://onlinelibrary.wiley.com/doi/10.1111/dth.15017

Lupus exacerbation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/

Systemic lupus following vaccination: https://pubmed.ncbi.nlm.nih.gov/34418261/

Relapse of class V lupus. Nephritis after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352310/

Subacute cutaneous lupus erythematosus flare triggered by Moderna: https://pubmed.ncbi.nlm.nih.gov/34455671/

Emergence of new onset SLE following vaccination: https://pubmed.ncbi.nlm.nih.gov/34450645/

Hyperglycemic crisis: https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14631

Perturbation of blood glucose following vaccination, a review of 20 adults: https://pubmed.ncbi.nlm.nih.gov/34375490/

Subacute Thyroiditis: https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1947102?fbclid=IwAR02FYW94iQGbu6e2uTpD42XoIwp6QHzwhDBWotULtT4ZCGR5sVKkyexbRg

Two cases of subacute thyroiditis after Moderna and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34504856/

Two cases of Graves disease following vaccination: https://pubmed.ncbi.nlm.nih.gov/33858208/

Two more cases of Graves disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34342859/

5 cases of adrenal crisis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34358373/

Myositis in a 56yoF following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/33647971/

mRNA induced rhabdomyolysis and fasciitis: https://pubmed.ncbi.nlm.nih.gov/34435250/

Rhabdomyolysis after Moderna: https://pubmed.ncbi.nlm.nih.gov/34150372/

21yoM with Pfizer induced rhabdomyolysis: https://pubmed.ncbi.nlm.nih.gov/34186348/

Quadrilateral space region inflammation and other incidental findings on shoulder MRI following Pfizer COVID-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34306275/

Rash, arthritis, swelling, muscle weakness following AstraZeneca: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27175

Polyarthralgia and Myalgia syndrome after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34463066/

40yoF with Henoch-Schonlein Purpura following Pfizer: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241653/

New onset mainly guttate psoriasis after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309932/

2 cases of exacerbation of plaque psoriasis after Pfizer and CoronaVac: https://pubmed.ncbi.nlm.nih.gov/34427024/

14 cases of psoriasis activation following vaccination (Moderna, Pfizer, and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34363647/

Pustuluar psoriasis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34398977/

Psorasis exacerbation after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34487570/

Arthritis in the L elbow following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363344/

Vasculitis and bursitis on 18F FDG-PET/CT following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34495381/

Remitting seronegative symmetrical synovitis with pitting edema following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34348912/

Scleroderma renal crisis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34339745/

Adult onset Still’s disease following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34316728/

Adult onset Still’s disease following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34316726/

Hyper-inflammation after COVID-19 mRNA vaccination: at the cross roads of multi-inflammatory disease and adult onset still’s disease:

https://pubmed.ncbi.nlm.nih.gov/34487678/

Immune mediated disease flares: https://pubmed.ncbi.nlm.nih.gov/33946748/

Local and systemic reactogenicity of Pfizer in patients with systemic lupus and rheumatoid arthritis: https://pubmed.ncbi.nlm.nih.gov/34476603/

Incidence of disease flare after Pfizer vaccination in patients with rheumatoid arthritis in remission: https://pubmed.ncbi.nlm.nih.gov/34472714/

11% of patients with rheumatic and MSK diseases report disease flare following 2 dose mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34346185/

Hematology

Superior ophthalmic Vein Thrombosis and Thrombocytopenia following AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265377/

Autoimmune hemolytic anemia: https://pubmed.ncbi.nlm.nih.gov/34150386/

Autoimmine hemolytic anemia following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34258873/

ITP and AIHA following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274740/

ITP Exacerbation in 12% of chronic patients: https://pubmed.ncbi.nlm.nih.gov/34075578/

ITP Exacerbation in previous stable patient following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34307734/

ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34155844/

ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34382388/

Secondary ITP and resulting hemorrhage and hematoma after minor oral surgery after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34314875/

ITP and diffuse papular rash following Moderna: https://www.scienceopen.com/document_file/691feaa0-8e64-40c4-9553-40382bd5ac48/PubMedCentral/691feaa0-8e64-40c4-9553-40382bd5ac48.pdf

ITP following Astrazeneca: https://ashpublications.org/blood/article/doi/10.1182/blood.2021012790/476455/Immune-Thrombocytopenic-Purpura-after-vaccination

ITP in 1st trimester of pregnancy 13 days following vaccination in the US: https://pubmed.ncbi.nlm.nih.gov/34420249/

84yoM with ITP following Pfizer: https://link.springer.com/article/10.1007/s11739-021-02778-w

41yoF with ITP following Pfizer: https://casereports.bmj.com/content/14/5/e242220

69yoF with refractory ITP following Pfizer: https://journals.lww.com/americantherapeutics/Citation/2021/08000/Immune_Thrombocytopenic_Purpura_Associated_With.24.aspx

20yoF with ITP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34381692/

54yoF with ITP following Pfizer: https://www.cureus.com/articles/56899-newly-diagnosed-idiopathic-thrombocytopenia-post-covid-19-vaccine-administration

74yoM with ITP following Moderna: https://www.dovepress.com/severe-refractory-immune-thrombocytopenia-occurring-after-sars-cov-2-v-peer-reviewed-fulltext-article-JBM

26yoF with ITP and acute liver injury following Moderna: https://pubmed.ncbi.nlm.nih.gov/34330722/

26yoF with ITP following Moderna: http://pubs.sciepub.com/ajmcr/9/8/3/index.html

63yoF with ITP following Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34469919/

68yoF with ITP following Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385179/

86yoM with ITP following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34446449/

41yoM with ITP following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34377889/

3 cases of ITP following Pfizer and Astra Zeneca: https://www.mjhid.org/index.php/mjhid/article/view/4669/4043

3 cases reports of ITP following Pfizer and J&J: https://ehoonline.biomedcentral.com/articles/10.1186/s40164-021-00235-0

3 cases: recurrent AvWD and acquired hemophilia A after Moderna, PNH flare following Moderna, and ITP flare following Moderna: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-and-complement-mediated-hematologic

3 cases of ITP in elderly patients following vaccination: https://www.hindawi.com/journals/crihem/2016/7913092/

36 Cases of ITP following Pfizer and Moderna: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011062/

PE, TIA, and thrombocytopenia after J&J: https://pubmed.ncbi.nlm.nih.gov/34261635/

DVT and PE and positive HIT panel following mRNA Vaccine: https://pubmed.ncbi.nlm.nih.gov/34117206/

3 patients with venous thromboembolism following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34352418/

Thrombosis with Thrombocytopenia following Moderna: https://www.acpjournals.org/doi/full/10.7326/L21-0244

TTP Following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34264514/

Acquired TTP following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34309715/

TTP in an adolescent following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34405400/

Thrombocytopenia in a teen with sickle cell disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34331506/

Safety warning for AstraZeneca in patients with sickle cell disease: https://mjhid.org/index.php/mjhid/article/view/4708?fbclid=IwAR2kMtsqqwiYyxxQ9XxIvDFdOSt-yTPqjAro-fgaEp460JeHd0QwBxx4DPg

5 cases of prothrombotic immune thrombocytopenia after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34323939/

20 cases of Thrombocytopenia following Pfizer and Moderna: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26132

Review of 50 cases of thrombocytopenia following Astrazeneca, Pfizer, Moderna: https://pubmed.ncbi.nlm.nih.gov/34332437/

68yoF with extensive thrombosis after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34400433/

Thrombotic Thrombocytopenia after AstraZeneca: Autopsy findings: https://pubmed.ncbi.nlm.nih.gov/34355379/

Fatal ICH due to Thrombotic Thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34402235/

Five cases with a combination of cerebral venous thrombosis, intracerebral hemorrhage and thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34393988/

Confusion and abdominal pain due to VITT following vaccination: https://pubmed.ncbi.nlm.nih.gov/34346657/

Fatal thromboembolism in a patient with preexisting thrombocytopenia following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34344867/

Malignant CVA due to VITT following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34341358/

3 cases of immune thrombocytopenia following AstraZeneca in Thailand: https://pubmed.ncbi.nlm.nih.gov/34483267/

Treatment Guide to Thrombotic Thrombocytopenia Following Vaccination: https://www.hematology.org/covid-19/vaccine-induced-immune-thrombotic-thrombocytopenia

Successful venous thromboprophylaxis in a patient with AstraZeneca induced VITT: https://pubmed.ncbi.nlm.nih.gov/34496889/

Autoimmunity roots of the thrombotic events following COVID vaccination: https://pubmed.ncbi.nlm.nih.gov/34508917/

Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways: https://pubmed.ncbi.nlm.nih.gov/34479129/

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34474550/

The known knowns and known unknowns of vaccine-induced thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34472568/

Skin, nose, and gingival bleeding episodes after AstraZeneca: a large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/

Haemophagocytosis and atypical lymphocytes on bone marrow biopsy following vaccination: https://pubmed.ncbi.nlm.nih.gov/34312842/

3 cases of HLH following AstraZeneca: https://jcp.bmj.com/content/early/2021/07/22/jclinpath-2021-207760

Coagulopathies after vaccination against SARS-COV-2 may be derived from a combo of spike protein and adenovirus vector-triggered signaling pathways: https://arxiv.org/abs/2109.00089?fbclid=IwAR2orycgbxqSNXLR9A4XjNwEAZBumiRbRKsfW8KL5qiJCXSWwqmLiMtc4Z4

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia: https://pubmed.ncbi.nlm.nih.gov/34455073/

Oncology

Axillary lymphadenopathy following mRNA vaccination:

https://pubmed.ncbi.nlm.nih.gov/34156552/

Ipsilateral axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34333959/

4 cases of axillary adenopathy following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34303188/

Axillary adenopathy following AstraZeneca resulting in possible misinterpretation of PET scan in metastatic melanoma patient: https://pubmed.ncbi.nlm.nih.gov/34414110/

163 cases of axillary adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34257025/

Incidence of axillary adenopathy on Breast Imaging following Vaccination: https://pubmed.ncbi.nlm.nih.gov/34292295/

Supraclavicular lymphadenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34414929/

Cervical lymphadenopathy following Pfizer:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204135/

13 cases of Cervical lymphadenopathy: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241354/

50yoM with adenopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34406229/

Review of 24 cases of lymphadenopathy and their ultrasound findings in the US: https://pubmed.ncbi.nlm.nih.gov/34356507/

Kikucki-Fujimoto disease following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34395192/

Mammographic and sonographic findings in the breast and axillary tail following vaccination: https://pubmed.ncbi.nlm.nih.gov/34340203/

Vaccine related unilateral axillary lymphadenopathy:pattern on screening breast MRI: https://pubmed.ncbi.nlm.nih.gov/34325221/

Evolution of lymphadenopathy at PET/MRI after vaccination: https://pubmed.ncbi.nlm.nih.gov/34310229/

Axillary lymphadenopathy after COVID vaccination in patients with thoracic malignancy: https://pubmed.ncbi.nlm.nih.gov/34506955/

DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson: https://pubmed.ncbi.nlm.nih.gov/34269723/

DOTATOC-avid lymphadenopathies induced by mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34363083/

3 cases of supraclavicular and axillary lymphadenopathy induced by vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT: https://pubmed.ncbi.nlm.nih.gov/34507331/

FDG uptake in axillary lymph nodes after vaccination: a pitfall case of highly suspicious lymph nodes metastases of malignant melanoma: https://pubmed.ncbi.nlm.nih.gov/34412144/

Avid left axillary nodes and intense diffuse splenic uptake and moderate diffuse bone marrow uptake on PET 1 week after vaccination: https://pubmed.ncbi.nlm.nih.gov/34269722/

Vaccination effect on tracer uptake with FDG-PET/CT: https://pubmed.ncbi.nlm.nih.gov/34297113/

Abnormal PET following vaccination: https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.29262

Positive PET following vaccination: https://pubmed.ncbi.nlm.nih.gov/34301777/

False Positive FDG PET CT after vaccination in a woman treated for metastatic breast cancer: https://pubmed.ncbi.nlm.nih.gov/34308402/

The day after mass COVID vaccination: higher hypermetabolic lymphadenopathy detection on PET/CT and impact on oncologic management: https://pubmed.ncbi.nlm.nih.gov/34503150/

Temporal metabolic response to mRNA vaccinations in oncology patients: https://pubmed.ncbi.nlm.nih.gov/34463888/

Thymic hyperplasia after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34462647/

Fatal systemic capillary leak syndrome after Johnson and Johnson vaccination in a multiple myeloma patient: https://pubmed.ncbi.nlm.nih.gov/34459725/

Moderna vaccination mimicking lymph-node progression in a patient with melanoma: https://pubmed.ncbi.nlm.nih.gov/34433198/

Post vaccination lymphadenopathy: report of cytological findings from fine needle aspiration biopsy: https://pubmed.ncbi.nlm.nih.gov/34432391/

Rituximab-induced acute lympholysis and pancytopenia after Moderna in a 71yoM with b-cell lymphoplasmacytic lymphoma: https://pubmed.ncbi.nlm.nih.gov/34429981/

Dermatology/Plastics:

60yo with Steven Johnson Syndrome: https://pubmed.ncbi.nlm.nih.gov/34081806/

Steven Johnson Syndrome following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34384729/

Pemphigus Vulgaris:

https://pubmed.ncbi.nlm.nih.gov/34169588/

Morbilliform Rash:

https://pubmed.ncbi.nlm.nih.gov/34167874/

Pityriasis-rosea like eruption post-vaccination in a young male: https://pubmed.ncbi.nlm.nih.gov/34165237/

Pityriasis rosea following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17498

66yoM with Pityriasis rosea after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34435935/

1 case of Pityriasis rosea and 3 cases of urticaria following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34478204/

A case series of Pityriasis rosea following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363731/

Two cases of papulo-pustular rosacea-like eruptions following Pfizer and AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416044/

Pityriasis rubra pilaris following Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34310778/

Pityriasis rubra pilaris in 72yoM following Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34420983/

Pityriasis Rubra Pilaris like eruption following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34379821/

3 cases of new onset acral hand lesions following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34310777/

2 patients with eczematous cutaneous reactions following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236729/

New onset synovitis and palmoplantar psoriasis flare up after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236728/

Exacerbation of Hailey-Hailey Disease following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34436620/

New onset lichen planus following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17504

Lichen striatus: https://pubmed.ncbi.nlm.nih.gov/34423105/

Purpura annularis telangiectodes following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34236717/

Flagellate Purpura following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34416052/

Symmetrical drug related intertriginous and flexural exanthema like eruption following AztraZeneca: https://pubmed.ncbi.nlm.nih.gov/34399001/

Vitiligo following Pfizer: https://onlinelibrary.wiley.com/doi/10.1111/ced.14842

Vitiligo in a Ulcerative Colitis Patient following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34498300/

Bacillus Calmette-Guerin scar flare after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34344774/

Palms and Soles Itchiness following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34391695/

Resistant pruritis skin rash following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34358176/

Necrotic eschars at injection sites one week after 2nd dose of Pfizer: https://pubmed.ncbi.nlm.nih.gov/34337117/

Facial Pustular Neutrophilic Eruption following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34319363/

Acute generalized exanthematous pustulosis induced by Moderna: https://pubmed.ncbi.nlm.nih.gov/34466640/

AstraZeneca induced acute localized exanthematous pustulosis: https://pubmed.ncbi.nlm.nih.gov/34487574/

Delayed local skin reactions: https://www.nejm.org/doi/full/10.1056/NEJMc2102131?fbclid=IwAR0P6wjXiO4swT4wz0lEJCBx7v14e2Si-O9AbOuhlVisVHFhc_kGEy7pyj0

Delayed skin reactions following mRNA vaccine: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288253/

11 patients with delayed skin reaction after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34433495/

Additional 12 Patients with Delayed Local Reactions: https://www.nejm.org/doi/full/10.1056/NEJMc2102131

16 patients delayed hypersensitivity reactions after Moderna: https://jamanetwork.com/journals/jamadermatology/fullarticle/2779643

138 Delayed Hypersensitivity Reactions following vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294276/

Delayed local Hypersensitivity reactions: a 6 month retrospective study: https://pubmed.ncbi.nlm.nih.gov/34288056/

Delayed cutaneous hypersensitivity reaction following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34351606/

Cutaneous skin manifestation following Moderna with Hypersensitivity reaction Histopathology: https://pubmed.ncbi.nlm.nih.gov/34414254/

2 cases of delayed local reactions following Moderna: https://journals.lww.com/infectdis/Fulltext/2021/07000/Delayed_Skin_Rash_After_Receiving_SARS_CoV_2_mRNA.19.aspx

4 cases of cutaneous hypersensitivity reactions following Moderna: https://pubmed.ncbi.nlm.nih.gov/34485656/

5 Japanese cases of delayed large local reactions to Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34459023/

13 cases delayed local reactions following mRNA vaccine: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab518/6291929

COVID Vaccine arm: https://www.psychologytoday.com/us/blog/heal-the-mind-heal-the-body/202101/what-s-the-new-phenomenon-called-covid-vaccine-arm

COVID arm following Moderna: histologic features: https://pubmed.ncbi.nlm.nih.gov/34242422/

Covid vaccine arm may present after both mRNA vaccines vaccination: https://pubmed.ncbi.nlm.nih.gov/34416053/

405 cases of dermatologic reactions following Pfizer, Moderna, and Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34254291/

Erythema Migrans like rash after Moderna: https://pubmed.ncbi.nlm.nih.gov/34250736/

Bullous Drug Eruption Rash following Moderna: https://pubmed.ncbi.nlm.nih.gov/34294590/

Bullous eruption following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34416058/

Bullous Fixed Drug Eruption following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34482558/

Atypical erythema multiforme related to Pfizer vaccine: https://pubmed.ncbi.nlm.nih.gov/34473839/

Soft Tissue Filler Inflammatory Reaction after vaccination:

https://pubmed.ncbi.nlm.nih.gov/34174156/

Immune Response to fillers and breast implants after vaccination: https://pubmed.ncbi.nlm.nih.gov/34174765/

Breast Implant seroma after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34405902/

L Breast Implant Capsular Contracture following Moderna vaccination: https://pubmed.ncbi.nlm.nih.gov/34373851/

COVID-toes after mRNA vaccination:

https://pubmed.ncbi.nlm.nih.gov/34162525/

Leukoclastic vasculitis: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41910

Urticarial Vasculitis following vaccination: https://journals.lww.com/amjdermatopathology/Citation/9000/Unique_Case_of_Urticarial_Skin_Eruptions_After.97698.aspx

Urticarial Vasculitis: https://pubmed.ncbi.nlm.nih.gov/34369046/

Small vessel vasculitis after Astra Zeneca: https://pubmed.ncbi.nlm.nih.gov/34310763/

Cutaneous small vessel vasculitis following J&J: https://pubmed.ncbi.nlm.nih.gov/34337124/

Cutaneous lymphocytic vasculitis following mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34327795/

Pfizer induced reactivation of varicella and resulting small vessel vasculitis: https://pubmed.ncbi.nlm.nih.gov/34310759/

2 cases of skin color discoloration following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34310755/

A case series of rare cutaneous adverse events following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363637/

Moderna Vaccine Induced Skin Rash: https://pubmed.ncbi.nlm.nih.gov/34423142/

A Case series of Cutaneous vaccine reactions at Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/

Clinicopathological features of cutaneous reactions after mRNA vaccines, 11 cases: https://pubmed.ncbi.nlm.nih.gov/34459036/

3 cases of vesiculobullous non-IgE-mediated cutaneous reactions to Pfizer: https://pubmed.ncbi.nlm.nih.gov/34363258/

A narrative review of cutaneous and hypersensitivity reactions: https://pubmed.ncbi.nlm.nih.gov/34424434/

SARS-CoV-2 Vaccines and the Skin: https://pubmed.ncbi.nlm.nih.gov/34483343/

Ophthalmology:

Acute Macular Neuroretinopathy after AstraZeneca:

https://www.nature.com/articles/s41433-021-01610-1.epdf...

Acute macular neuroretinopathy following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34485760/

Acute Central Serous Retinopathy after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34151047/

Panuveitis: https://pubmed.ncbi.nlm.nih.gov/34213988/

Reduction of Visual Acuity following Pfizer: https://link.springer.com/article/10.1007/s00011-021-01476-9?fbclid=IwAR3zAvenOwPAZmuVsx9CM7bFwOliHerfJK3M3nQCMe-3BWoT4QdNCWK7cNo

Corneal graft rejection after Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34426655/

Bilateral Retinal Detachments 10 days after mRNA vaccination 22yoF : https://www.jem-journal.com/article/S0736-4679(21)00611-9/fulltext

Central Retinal Vein Occlusion occuing immediately after 2nd dose of mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34426861/

Transient Oculomotor palsy following mRNA. Vaccine: https://pubmed.ncbi.nlm.nih.gov/34369471/

Anterior Uveitis following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34289406/

21 cases of Uveitis following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34369440/

A case of bilateral arteritic anterior ischemic optic neuropathy and a case of bilateral acute zonal occult outer retinopathy after mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34394876/

Vaccination and Bilateral Multifocal Choroiditis: https://pubmed.ncbi.nlm.nih.gov/34406890/

34yoM with bilateral multifocal choroiditis following 2nd dose vaccination: https://pubmed.ncbi.nlm.nih.gov/34344280/

Acute painless bilateral blurring of vision following Pfizer due to Vogt-Koyanagi-Hara disease: https://pubmed.ncbi.nlm.nih.gov/34505819/

Eyelid erythema after Pfizer vaccination: https://pubmed.ncbi.nlm.nih.gov/34426009/

Reactivation of herpes simplex keratitis following AstraZeneca vaccination: https://pubmed.ncbi.nlm.nih.gov/34493563/

2 cases of Ipsilateral zoster opthalmicus after Moderna and Johnson and Johnson: https://pubmed.ncbi.nlm.nih.gov/34471577/

Bilateral immune mediated keratolysis following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34483273/

COVID-19, COVID-19 vaccinations, and subsequent abnormalities in the retina: causation or coincidence? https://pubmed.ncbi.nlm.nih.gov/34473193/

ENT

3 cases of Tinnitus following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34120553/

18 cases of idiopathic sensorineural hearing loss, tinnitus, and/or vertigo following Moderna/Pfizer: https://pubmed.ncbi.nlm.nih.gov/34267103/

Tinnitus/cochleopathy following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34297133/

Lipschutz ulcers after AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34366434/

Herpes Zoster following Moderna: https://pubmed.ncbi.nlm.nih.gov/34397201/

Herpes Zoster reactivation following Moderna: https://pubmed.ncbi.nlm.nih.gov/34316506/

Ramsy Hunt syndrome following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34344559/

A case series of Herpes Zoster following AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34363717/

2 cases of herpes zoster following Pfizer: https://pubmed.ncbi.nlm.nih.gov/34428545/

2 cases of herpes zoster in healthy young adults following vaccination: https://pubmed.ncbi.nlm.nih.gov/34363257/

3 cases of Herpes Zoster following Vaccination (Moderna and AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34293165/

3 cases of Herpes Zoster after covid vaccination in patients with chronic urticaria being treated with cyclosporine: https://pubmed.ncbi.nlm.nih.gov/34510694/

4 cases of Herpes Zoster (2 pfizer, 2 astrazeneca): https://pubmed.ncbi.nlm.nih.gov/34310754/

6 cases of Herpes Zoster following Pfizer: https://pubmed.ncbi.nlm.nih.gov/33848321/

A case of varicella-zoster virus after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34390376/

Varicella zoster reactivation and mRNA vaccines as a trigger: https://pubmed.ncbi.nlm.nih.gov/34316507/

40 cases of HSV and VZV reactivation following mRNA vaccination: https://pubmed.ncbi.nlm.nih.gov/34487581/

Miscellaneous:

Multisystem inflammatory syndrome in an adult following Pfizer (MIS-V): https://pubmed.ncbi.nlm.nih.gov/34326117/

3 cases of Multisystem Inflammatory Syndrome after Pfizer: https://pubmed.ncbi.nlm.nih.gov/34034858/

Hypertension following mRNA vaccination:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206586/

POTS following Pfizer: https://www.cureus.com/articles/56242-a-case-of-postural-orthostatic-tachycardia-syndrome-secondary-to-the-messenger-rna-covid-19-vaccine

Vaccine induced interstitial lung disease in 86yoM after mRNA vaccine: https://pubmed.ncbi.nlm.nih.gov/34362838/

Vaccine induced interstitial lung disease: https://pubmed.ncbi.nlm.nih.gov/34510014/

Pulmonary Embolus following Moderna: https://pubmed.ncbi.nlm.nih.gov/34452028/

Concerns for Pfizer vaccine failure to wildtype variants after Delta and vaccine induced enhanced illness, as demonstrated in a mice model: https://www.biorxiv.org/content/10.1101/2021.08.22.457114v1.full.pdf

International call for vaccine adverse reaction investigation: https://www.researchgate.net/publication/351670290_SARS-CoV-2_mass_vaccination_Urgent_questions_on_vaccine_safety_that_demand_answers_from_international_health_agencies_regulatory_authorities_governments_and_vaccine_developers?fbclid=IwAR1Gwfel6khY8ObziHNTGZriwS0Gez0CCp8zjaHllCJ9lfceD2EkJdMKmYw

Concerns about the lipid nanoparticle in the mRNA contributing to adverse reactions: https://www.biorxiv.org/content/10.1101/2021.03.04.430128v1.full?fbclid=IwAR2yUJH9kAb01O2PJ46AfBvQANuGiQvZd3ROs4R8qNJF6CZ4f255hDdRsSY

Medscape Health Care Professional Adverse Reactions: https://www.medscape.com/sites/public/covid-19/vaccine-insights/how-concerned-are-you-about-vaccine-related-adverse-events?src=soc_fb_share&fbclid=IwAR1zS9dnzVFRxBghSFv3hjdtinVxBkQJiopbY4fbFCKvyEgsw9TXokQ7b0I

Facebook link to reactions: https://www.facebook.com/profile.php?id=100068922816380